Skip to content

Clinical trials

Hepatitis C, Chronic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Country / region: Belgium Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20062
20076
20083
20093
20103
20115
20128
20131
20141
20153
20161
20173
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
AbbVie4
Debiopharm International SA4
Janssen-Cilag International NV4
Atea Pharmaceuticals, Inc.3
GlaxoSmithKline3
Boehringer Ingelheim2
Gilead Sciences2
Novartis Pharmaceuticals2
Tibotec BVBA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic45
Hepatitis C20
Fibrosis3
Infections3
Hepatitis2
Drug Misuse1
Flaviviridae Infections1
Hepatitis, Chronic1
Hepatitis, Viral, Human1
Liver Cirrhosis1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.